WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹1,235 Cr | ₹887 Cr | ₹617 Cr | ₹-22 Cr | ₹261 Cr |
What is the latest Total Non-Current Liabilities ratio of WOCKHARDT ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹1,235 Cr |
| Mar2025 | ₹887 Cr |
| Mar2024 | ₹617 Cr |
| Mar2023 | ₹-22 Cr |
| Mar2022 | ₹261 Cr |
How is Total Non-Current Liabilities of WOCKHARDT Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,235 Cr | 39.23 | |
| Mar2025 | ₹887 Cr | 43.76 | |
| Mar2024 | ₹617 Cr | Positive | |
| Mar2023 | ₹-22 Cr | Negative | |
| Mar2022 | ₹261 Cr | - | |
Compare Total Non-Current Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹30,048.7 Cr | -0.8% | -7.5% | 3.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,842.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,860.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹192,687.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹112,593.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,364.9 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -0.8% |
-7.5% |
3.5% |
| SENSEX | -1% |
-0.9% |
-7.5% |
You may also like the below Video Courses